National Research Program
The Leukaemia Foundation's National Research Program funds important research into the causes, diagnosis, management and cures of leukaemias, lymphomas, myeloma and related blood disorders. Applications are now open for our 2008 grants, fellowships & scholarships.
The Leukaemia Foundation Research Unit at the Queensland Institute of Medical Research in 1992. The Unit continues to work at the forefront of international research and is led by Professor of Experimental Haematology, Andrew Boyd who is recognised around the world as a leader in haematological research.
In 2002, Australia's first national blood tissue bank, the PwC Foundation Leukaemia and Lymphoma Tissue Bank was launched by the Leukaemia Foundation and the Australasian Leukaemia and Lymphoma Group (ALLG). The Tissue Bank provides researchers access to larger collections of samples for laboratory studies to improve our understanding of the development of these cancers and responses to the treatments.
The Leukaemia Foundation also seeks to encourage innovative Australian research through the provision of grants-in-aid as well as funding scholarships and fellowships to foster the careers of talented researchers. The Leukaemia Foundations National Research Program is listed on Australian Competitive Grants Register.
National Medical and Scientific Advisory Committee
National Medical and Scientific Advisory Committee (NMSAC) was established in 2000 to provide strategic advice to the Leukaemia Foundation on medical, scientific, research and clinical matters. Members of the NMSAC are qualified and practising haematologists. Each member of the NMSAC represents their state Scientific and Medical Advisory Committee and may also perform the role of Medical Advisor in their state. The Chair of the NMSAC is also the National Medical Advisor for the Foundation and is a member of the Leukaemia Foundation of Australia Board.
The NMSAC oversees and guides the National Research Program and the scientific and medical research granting process which is undertaken by an independent panel of experts - the Grants Review Committee (GRC) chaired by Prof Andrew Boyd. The NMSAC makes medical and research funding recommendations to the LFA Board based on advice received from the GRC ensuring that the recommendations are consistent with LFA goals and priorities.
The current Chairman of the NMSAC is Assoc Prof Ken Bradstock (NSW) and the other members of the committee are Dr Paula Marlton (Qld), Professor Andrew Boyd (Qld), Dr Andrew Spencer (Vic), Dr Richard Herrmann (WA), Dr Briony Kuss (SA), Ms Sandy McKiernan (WA), Dr Geoff Hill (Qld) and Dr Angel Lopez (SA).
National Grants Review Committee
All applications are reviewed by our National Grants Review Committee (GRC). This Committee operates under the direction of, and provides funding advice to, the National Medical & Scientific Advisory Committee and is chaired by Professor Andrew Boyd (QIMR, UQ). The GRC is an independent panel of leading researchers who review applications and make recommendations to the NMSAC concerning which grants, fellowships and scholarships the Leukaemia Foundation should fund.
